文献速递医学教育与科研方法

纳入试验的疗效-效果谱系评级:一种用于系统评价的新工具的开发

Rating of Included Trials on the Efficacy-Effectiveness Spectrum: development of a new tool for systematic reviews.
PubMed 文献 · J Clin Epidemiol · 2017-02-07

本研究开发了RITES工具,从参与者特征、试验环境、干预灵活性和干预临床相关性四个维度,用五点李克特量表对系统评价纳入的随机试验进行疗效-效果谱系评级。在三个系统评价的试验中由无关评级者试用时评级变异较大(ICC 0.25-0.66),而在一个由具备主题专业知识的系统评价作者使用的评价中评级一致(ICC>0.80)。

要点

  • RITES工具从四个维度用五点李克特量表评级随机试验的疗效-效果谱系。
  • 由无关评级者试用时四个维度ICC为0.25-0.66,评级变异较大。
  • 由具备主题专业知识的系统评价作者使用时ICC>0.80,评级一致。

核心结论

  • RITES可能有助于表征系统评价纳入试验的疗效-效果性质。

研究设计与样本

  • 从现有工具提取评级领域和描述词,采用改良德尔菲程序精简领域并开发新工具,并在四个系统评价的试验中检验其可行性和评级者间信度。

主要发现

  • RITES从参与者特征、试验环境、干预灵活性和干预临床相关性四个领域用五点李克特量表评级临床试验。
  • 由无关评级者对三个系统评价的试验进行试用时,四个领域的组内相关系数(ICC)为0.25-0.66,评级存在变异。
  • 由一个系统评价的作者(具备该主题专业知识)使用时,ICC>0.80,评级一致。

关键数值与推荐

  • RITES采用五点李克特量表,评级四个领域:参与者特征、试验环境、干预灵活性、干预临床相关性。
  • 无关评级者试用时四个领域ICC为0.25-0.66;具备主题专业知识的系统评价作者使用时ICC>0.80。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Randomized trials may be designed to provide evidence more strongly related to efficacy or effectiveness of an intervention. When systematic reviews are used to inform clinical or policy decisions, it is important to know the efficacy-effectiveness nature of the included trials. The objective of this study was to develop a tool to characterize randomized trials included in a systematic review on an efficacy-effectiveness continuum. METHODS: We extracted rating domains and descriptors from existing tools and used a modified Delphi procedure to condense the domains and develop a new tool. The feasibility and interrater reliability of the tool was tested on trials from four systematic reviews. RESULTS: The Rating of Included Trials on the Efficacy-Effectiveness Spectrum (RITES) tool rates clinical trials on a five-point Likert scale in four domains: (1) participant characteristics, (2) trial setting, (3) flexibility of interventions, and (4) clinical relevance of interventions. When RITES was piloted on trials from three reviews by unaffiliated raters, ratings were variable (intraclass correlation coefficient [ICC] 0.25-0.66 for the four domains); but, when RITES was used on one review by the review authors with expertise on the topic, the ratings were consistent (ICCs > 0.80. CONCLUSION: RITES may help to characterize the efficacy-effectiveness nature of trials included in systematic reviews.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Wieland LS, Berman BM, Altman DG, et al. Rating of Included Trials on the Efficacy-Effectiveness Spectrum: development of a new tool for systematic reviews. J Clin Epidemiol. 2017. PMID: 28188898. doi:10.1016/j.jclinepi.2017.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。